Nama's AI scorecard currently rates Cognex Strong Buy (8.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CGNX's P/E ratio?

Cognex trades at a trailing price-to-earnings ratio of 30.1.

When does CGNX report earnings?

Cognex's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $0.39.

What is the CGNX price target?

The median analyst price target from 19 analysts is $80.00, with a range of $60.00 – $92.00.

Is CGNX Shariah compliant?

Nama's AAOIFI-style screen reads Cognex as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does CGNX pay a dividend?

Yes — Cognex's dividend yield is 0.7%.

Nama Insights

Cognex (CGNX)

Technology · Scientific Technical Instruments · NASDAQ

Cognex (CGNX) is a Technology company in the Scientific Technical Instruments industry. It has a market capitalization of $8.04B, a trailing price-to-earnings ratio of 30.1 and a free-cash-flow yield of 2.9%. Over the most recent reported fiscal year, revenue grew 8.7% and free cash flow per share grew 80.0%. Nama's AI scorecard rates it Strong Buy, 8.7 out of 10. On 12-month momentum it ranks in the leading band of its market.

AI scorecard

Strong Buy · 8.7/10

The top band of the Fundamental Verdict (8.6–10). As of Nov 7, 2026.

Momentum

Leading · +54.8% over 12 months ex. last

Top 20% of its market on the past year's steady rise.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-43.6%

How far the last close sits under the highest price of the past five years.

Market cap	$8.04B
Trailing P/E	30.1
Price / book	4.9
Price / sales	7.4
FCF yield	2.9%
Dividend yield	0.7%
Gross margin	68.9%
Operating margin	21.9%
Net margin	16.1%
Revenue growth (YoY)	+8.7%
Revenue growth (3-yr annual)	-0.4%
EPS growth (YoY)	+36.5%
FCF/share growth (YoY)	+80.0%
Beta	1.5
Exchange	NASDAQ
Sector	Technology
Industry	Scientific Technical Instruments

CGNX earnings

Next report: Feb 10, 2027 (Q4 2026, EPS estimate $0.39). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 4, 2026	$0.53	$0.52	+1.9%	$313.39M
Q2 2026	Aug 5, 2026	$0.45	$0.42	+7.1%	$291.26M
Q1 2026	May 6, 2026	$0.34	$0.25	+36.0%	$268.44M
Q4 2025	Feb 11, 2026	$0.27	$0.22	+22.7%	$252.34M

CGNX analyst price target

Median target $80.00 from 19 analysts, ranging $60.00 – $92.00.

Scientific Technical Instruments peers

Ticker	Company	Market cap	P/E
GRMN	Garmin	$55.03B	27.4
KEYS	Keysight Technologies	$46.33B	27.2
COHR	Coherent	$37.98B	29.5
TDY	Teledyne Technologies	$28.68B	24.6
FTV	Fortive	$19.46B	21.0
MKSI	MKS	$13.00B	15.7
TRMB	Trimble	$12.40B	15.4
ESE	ESCO Technologies	$5.97B	28.6

Explore live CGNX data on Nama Insights →

Recent Congressional trades

Cognex trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Sheldon Whitehouse	Senate	Sell	$15,001 - $50,000	—
Sheldon Whitehouse	Senate	Buy	$15,001 - $50,000	—
Thomas R Tillis	Senate	Sell	$1,001 - $15,000	—

CGNX FAQ

Is CGNX a buy?: Nama's AI scorecard currently rates Cognex Strong Buy (8.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CGNX's P/E ratio?: Cognex trades at a trailing price-to-earnings ratio of 30.1.
When does CGNX report earnings?: Cognex's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $0.39.
What is the CGNX price target?: The median analyst price target from 19 analysts is $80.00, with a range of $60.00 – $92.00.
Is CGNX Shariah compliant?: Nama's AAOIFI-style screen reads Cognex as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does CGNX pay a dividend?: Yes — Cognex's dividend yield is 0.7%.